Company: SLDE
Filing Date: 2025-01-22
Form Type: DRS/A
Source: 0000950123-25-000502
Chunk: 205

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-01-22
Form: DRS/A
Chunk 205
---
 the number of shares of common stock listed next to its name in the following table:

| Name                     |     | Number of 
 Shares    |
| Barclays Capital Inc.    |     |           |
| Morgan Stanley & Co. LLC |     |           |
| Total                    |     |           |

The underwriters are committed to purchase all the common shares offered by us if they purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaultingunderwriters may also be increased or the offering may be terminated. The underwriters propose to offer the common shares directly to the public at the public offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of $ per share. Any such dealers may resell shares to certain other brokers or dealers at a discount of up to $ per share from the public offering price. After the initial offering of the shares to the public, if all of the common shares are not sold at the public offering price, the underwriters may change the offering price and the other selling terms. Sales of any shares made outside of the United States may be made by affiliates of the underwriters. Option to Purchase Additional Shares The selling stockholders have granted the underwriters the right to purchase an additional shares of common stock to cover over-allotments. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase additional shares. If any shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered. Commissions and Expenses The following table shows the per share and total public offering price, underwriting discounts and commissions, and proceeds before expenses to us and the selling stockholders. These amounts are shown assuming both no exercise and full exercise of the underwriters’ option to purchase additional shares. The underwriting fee is equal to the public offering price per share of common stock less the amount the underwriters pay to us and the selling stockholders for the shares.

|                                                                               |     | Per Share |     | Total    
 No       
 Exercise |     | Full     
 Exercise |
|:------------------------------------------------------------------------------|:----|:----------|:----|:---------|:----|:---------|
| Initial public offering price                                                 |     | $         |